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Abstract
Background: Tens of thousands of cardiac and vascular surgeries (CaVS) are performed on seniors in Canada and the United
Kingdom each year to improve survival, relieve disease symptoms, and improve health-related quality of life (HRQL). However,
chronic postsurgical pain (CPSP), undetected or delayed detection of hemodynamic compromise, complications, and related poor
functional status are major problems for substantial numbers of patients during the recovery process. To tackle this problem, we
aim to refine and test the effectiveness of an eHealth-enabled service delivery intervention, TecHnology-Enabled remote monitoring
and Self-MAnagemenT—VIsion for patient EmpoWerment following Cardiac and VasculaR surgery (THE SMArTVIEW,
CoVeRed), which combines remote monitoring, education, and self-management training to optimize recovery outcomes and
experience of seniors undergoing CaVS in Canada and the United Kingdom.
Objective: Our objectives are to (1) refine SMArTVIEW via high-fidelity user testing and (2) examine the effectiveness of
SMArTVIEW via a randomized controlled trial (RCT).
Methods: CaVS patients and clinicians will engage in two cycles of focus groups and usability testing at each site; feedback
will be elicited about expectations and experience of SMArTVIEW, in context. The data will be used to refine the SMArTVIEW
eHealth delivery program. Upon transfer to the surgical ward (ie, post-intensive care unit [ICU]), 256 CaVS patients will be
reassessed postoperatively and randomly allocated via an interactive Web randomization system to the intervention group or
usual care. The SMArTVIEW intervention will run from surgical ward day 2 until 8 weeks following surgery. Outcome assessments
will occur on postoperative day 30; at week 8; and at 3, 6, 9, and 12 months. The primary outcome is worst postop pain intensity
upon movement in the previous 24 hours (Brief Pain Inventory-Short Form), averaged across the previous 14 days. Secondary
outcomes include a composite of postoperative complications related to hemodynamic compromise—death, myocardial infarction,
and nonfatal stroke— all-cause mortality and surgical site infections, functional status (Medical Outcomes Study Short Form-12),
depressive symptoms (Geriatric Depression Scale), health service utilization-related costs (health service utilization data from
the Institute for Clinical Evaluative Sciences data repository), and patient-level cost of recovery (Ambulatory Home Care Record).
A linear mixed model will be used to assess the effects of the intervention on the primary outcome, with an a priori contrast of
weekly average worst pain intensity upon movement to evaluate the primary endpoint of pain at 8 weeks postoperation. We will
also examine the incremental cost of the intervention compared to usual care using a regression model to estimate the difference
in expected health care costs between groups.
Results: Study start-up is underway and usability testing is scheduled to begin in the fall of 2016.
Conclusions: Given our experience, dedicated industry partners, and related RCT infrastructure, we are confident we can make
a lasting contribution to improving the care of seniors who undergo CaVS.
(JMIR Res Protoc 2016;5(3):e149)  doi: 10.2196/resprot.5763
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Introduction
Background
Cardiac and vascular surgeries (CaVS) are performed on seniors
[1] to improve survival and health-related quality of life
(HRQL). Unfortunately, chronic postsurgical pain (CPSP),
delayed detections of hemodynamic compromise, complications,
and related poor functional status are major problems for
substantial numbers of recovering patients [1]. This reflects the
inadequacy of current systems for patient monitoring after
CaVS, both on hospital surgical wards and at home. The current
approach (eg, manually checking vital signs every 8-12 hours
on postsurgical wards) results in thousands of cases of delayed
detection of hemodynamic compromise (eg, low blood pressure
and hypoxia) leading to severe complications (eg, myocardial
infarction and stroke) [2] and drastically reduced HRQL. To
tackle this problem, our aim is to refine and test the effectiveness
of the eHealth-enabled service delivery intervention,
TecHnology-Enabled remote monitoring and
Self-MAnagemenT—VIsion for patient EmpoWerment
following Cardiac and VasculaR surgery (THE SMArTVIEW
CoVeRed), which combines remote automated monitoring,
education, and self-management training to optimize recovery
in seniors undergoing CaVS, internationally.
Population, Challenges, Gaps, and Inefficiencies to be
Addressed
Overview
Collectively as an innovation community we have completed,
or are conducting, prospective outcome studies with >65,000
surgical patients, including CaVS patients [3-12]. Based upon
the collective research and literature syntheses [13-15], CaVS
can be currently characterized by several clinical inefficiencies,
resulting in the key challenges discussed in the following
sections.
Chronic Postsurgical Pain and Related Consequences
CaVS surgeries affect pain-sensitive structures as they invade
muscle and visceral tissues, and involve the harvesting and
manipulation of vessels. Such surgical tissue insults lead to
pathological nervous system changes, collectively known as
sensitization [16]—a function of neuronal modifiability [17].
Sensitization increases pain sensitivity (ie, hyperalgesia),
augments the normal duration (ie, hyperpathia) and amplitude
of pain, and results in abnormal interpretation of nonpainful
stimuli as painful (ie, allodynia) [16]. In all cases, CPSP is, in
part, a function of unrelieved acute postoperative (postop) pain
that involves a transition phase [18] by virtue of these
pathological mechanisms. In our review of 26 studies (n=2033;
mean age 65.1 years) across 15 countries, CPSP prevalence
following CaVS [11,12,18-41] ranged from 17-56%. The 2013
Canadian prospective Cardiac (CARD) pain study (n=1010)
[11] reported more modestly varying CPSP prevalence rates of
40%, 22%, and 17% at 3, 6, and 12 months following surgery,
respectively; pain was most commonly located along the sternal
incision and saphenous vein harvesting sites. But other studies
have reported 1-year CPSP prevalence rates as high as 39%
[39] and 45% [40]. Rates of CPSP following vascular surgery
are similar in range (25%), with moderate to severe pain
typically presenting along the femoropopliteal bypass tunnel
[42].
The deleterious consequences of CPSP in CaVS—amidst
divergent surgical populations—are well-known, with numerous
studies reporting associations of CPSP with poor HRQL and
depressive disorder [11,12,18-43]. We meta-analyzed available
data [11,25,26,29,32,33,35] (see Multimedia Appendix 1) and
found that among seniors who undergo CaVS, there is a
statistically and clinically significant relationship between acute
postop pain and CPSP development (standardized mean
difference 0.28; 95% CI 0.12-0.44) (see Table 1). This
emphasizes the decades of research [44-53] which indicate that
CaVS patients have erroneous pain and pain medication beliefs
that obstruct acute postop pain management. In 2004,
Watt-Watson et al [46] found that up to 83% of CaVS patients
do not ask for pain medication when requiring it and that, on
average, <35% of prescribed analgesic dosages are routinely
administered [46]. Current studies indicate that this unfortunate
scenario remains unchanged. Cogan et al [53] recently found,
for example, that 36% of CaVS patients believed that “pain
medication should be spared until the pain is very severe” and
20% believed that “good patients do not speak of their pain.”
A gap revealed from this meta-analysis regarding CPSP was
that unrelieved acute postop pain requires more effective
intervention. A solution to this gap is that postop education,
support, and acute pain monitoring and management at home
are needed to prevent transition from acute postop pain to CPSP.
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Table 1. Meta-analysis: Differences in acute postoperative pain scores between those who do and do not develop chronic postsurgical pain.
Standardized mean difference inverse variance random effects
(95% CI)
Weight
(%)
Standardized mean difference
(SE)
Study
0.14 (0.06 to 0.22)24.20.14 (0.04)Choiniere et al 2014 [11]
0.07 (-0.15 to 0.29)17.30.07 (0.11)King et al 2008 [25]
0.13 (0.02 to 0.25)22.70.13 (0.06)Lahtinen et al 2006 [26]
0.96 (0.19 to 1.74)3.80.96 (0.39)Lee et al 2010 [35]
0.86 (0.53 to 1.19)12.30.86 (0.17)Steegers et al 2007 [29]
0.31 (-0.02 to 0.63)12.60.31 (0.17)van Gulik et al 2011 [33]
0.27 (-0.25 to 0.79)7.10.27 (0.25)van Gulik et al 2012 [32]
0.28 (0.12 to 0.44)N/AN/AaTotal
aN/A: not applicable.
Undetected Hemodynamic Compromise
CaVS are among the highest-risk surgeries and are associated
with substantial postop morbidity and mortality. Following an
immediate postop period of intensive care unit (ICU)
hemodynamic surveillance, vital signs monitoring after ICU
discharge is lacking. Most patients on surgical wards will have
vital signs evaluated once per 4-12 hours [54,55]. Such limited
in-hospital monitoring—followed by no daily monitoring at
home—is significantly associated with poor clinical outcomes.
For example, in a study from the Cleveland Clinic [56], nurses
blinded to continuous pulse oximetry for monitoring peripheral
oxygen saturation (SpO2) assessed their postop patients (n=594)
according to normal practice and detected a 5% incidence of
hypoxemia (SpO2< 90%). Blindly captured study oximetry,
however, detected that 37% of patients had one or more
continuous episodes of hypoxemia for ≥1 hour, and that 10%
of patients had at least one continuous episode (≥1 hour) of
hypoxemia where SpO2 was <85% [56]. Given that hypoxemia
for >5 minutes is associated with increased risk of myocardial
ischemia, suboptimal monitoring on surgical wards elevates
risks for patients. Studies have also demonstrated that continuous
electrocardiographic ST segment monitoring after surgery can
identify asymptomatic ischemia that is independently associated
with myocardial infarction [57-59]. A study of postop ST
segment depression followed 151 consecutive patients
undergoing major vascular surgery and assessed for postop
myocardial ischemia [57]. Approximately 85% of patients who
suffered postop cardiac events had preceding long-duration ST
segment depressions [57]. These data suggest that remote,
continuous, noninvasive ST segment monitoring systems can
identify impending cardiac events much sooner than the usual
practice of checking vital signs manually every 4-12 hours. The
same is true for cardiac postop arrhythmias. The incidence of
atrial fibrillation, in particular, is 20-40% after cardiac surgery,
with even higher rates (30-50%) after valvular surgery [60-62].
While most patients spend the first 12-24 hours after surgery
in the ICU, 70% of postop atrial fibrillation occurs over the first
4 days following surgery, suggesting that many occurrences
will be missed on surgical wards [63]. This common scenario
is risk elevating, given that atrial fibrillation imposes a three-fold
increase in hypotension and stroke [64,65].
Data from large randomized controlled trials (RCTs) also
suggest that blood pressure is a particularly important
independent predictor of postop cardiac complications and death.
The PeriOperative ISchemic Evaluation (POISE) trial [4]
randomized 8351 patients to extended-release metoprolol (mean
age 68.9 years) or placebo (mean age 69.1 years). Along with
a reduction in myocardial infarction, a clinically significant
increase in hypotension with metoprolol use was found (hazard
ratio [HR] 1.55; 95% CI 1.38-1.74). Overall, clinically
significant hypotension is associated with the largest
population-attributable risk for perioperative death and
perioperative stroke [4]. Following POISE, POISE-2 was an
international RCT of 10,010 patients with, or at risk of, vascular
disease undergoing noncardiac surgery, including vascular
surgery [5]. Analyses demonstrated that clinically important
hypotension was an independent predictor of subsequent risk
of myocardial infarction during 30-day follow-up (adjusted HR
1.37; 95% CI 1.16-1.62) [5]. A gap revealed from this analysis
was that current monitoring of patients after CaVS is inadequate,
with significant harm resulting from undetected postoperative
hypoxemia, arrhythmia, and hypotension. A solution to this gap
is remote automated noninvasive postoperative monitoring, for
30 days following discharge, to enhance detection of
hemodynamic compromise and reduce adverse event risk.
Surgical Site Infections
CaVS options are changing, with many patients choosing
percutaneous coronary interventions (PCIs) to address
vasculature blockages. This results in those undergoing CaVS
manifesting disease that is either too advanced or too
complicated for PCI. As such, CaVS patients—often with
multiple comorbidities—are at high risk for surgical site
infections (SSIs). In England, for example, SSIs occurred in
4.4% of patients (n=29,144) who underwent coronary artery
bypass grafting and 2.2% of patients (n=7256) who underwent
vascular surgery—in National Health Service hospitals from
April 2008 to March 2013 [66]. The median time to infection
identification was 12 days and 11 days after cardiac and vascular
surgery, respectively [66]. A recent systematic review—57
studies—has corroborated the commonality of these infection
rates and that SSIs, furthermore, have major consequences
including mortality, repeated surgical procedures, hospital
readmissions, and health-related economic burden [67].
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Evidence from established daily postoperative surveillance
systems in the United States suggests that daily wound
monitoring can prevent SSI progression—superficial/incisional
to deep wound/organ/space [68]. A gap revealed from this
analysis is that postop SSIs often manifest at home following
discharge and are potentially preventable [69]. A solution to
this gap would be daily postop wound monitoring for early
detection of, and to prevent progression of, SSIs that require
hospitalization.
Hospital Readmissions and Summary of Key Issues
Not only are CaVS among the highest-risk surgeries, they are
associated with high rates of hospital readmission. A 2014
prospective, multicenter cohort study—10 centers, 5185
patients—in Canada and the United States reported the rate of
all-cause 30-day readmission following cardiac surgery at 18.7%
[69]. Recent data (2014) from a large US registry (N=11,246)
showed comparable rates of 30-day unplanned readmissions
among major vascular surgery patients: 15.7%, infrainguinal
bypass [70]. Our particular focus on the aforementioned issues
is due to the unequivocal association with poor postoperative
functional recovery resulting in CPSP [11,12,18-41]; adverse
cardiac events due to hemodynamic compromise [54-59]; and
high rates of hospital readmission due to infection [66,69].
Postoperative infection, for example, is the most common reason
for readmission in Canada following cardiac surgery (17.1%)
[69]. Other important recovery challenges for seniors, requiring
intervention, include psychological morbidity (eg, anxiety and
depression) [71-77] and medication reconciliation [78].
Proposed eHealth Innovation-Enabled Care Delivery
Program
Intervention in Canada and the United Kingdom
This project is being undertaken in Canada and the United
Kingdom because (1) the gaps and inefficiencies following
CaVS are similar and (2) implementations of eHealth
innovations require attention to agile/scalable designs which
can be realized through efficient (ie, parallel) integration and
effectiveness testing across two health systems.
Targeting Seniors Recovering From Cardiac and
Vascular Surgery
Guided by the Integrated Vascular Health Blueprint for Ontario
[79] and the UK Department of Health Cardiovascular Disease
Outcomes Strategy [80], our aim is health service integration.
The fragmented nature of cardiac/vascular care threatens the
sustainability of health systems due to inefficiencies and waste.
Given that factors associated with poor recovery are common
to both sets of CaVS patients, we are aligned with the Canadian
Vascular Health Coalition strategy—see page 7 of the Integrated
Vascular Health Blueprint for Ontario [79]—of mapping and
implementing more integrated ways of addressing cardiac and
vascular disease-related burden.
Partnership Process and Technology Partners
Initial discussions have centered on eHealth Innovation
Partnership Program objectives, CaVS recovery challenges, and
potential partners’ orientation to improving patient experience,
willingness to codesign, and their match with desired partner
criteria. Further discussions reviewed respective technology
innovations and desired scope of involvement. As a result of
this process, we are fortunate to be working with Philips Canada,
QoC Health, XAHIVE, and mPath. These partners are drivers
of innovation, ranging from small to medium enterprises, to a
multinational organization.
Guiding Principles, Work to Date, and Patient-Oriented
Approach
The intervention has been designed according to Patients First:
Action Plan for Health Care [81]. Grounded in commitment to
efficiency and integration of care, the following tenets of
Patients First serve as our guiding principles: (1) Improve
access: provide faster access to the right care by removing
barriers to full scope of practice and coordinating care, (2)
Connect patients to services: deliver integrated care that is home
based when possible, (3) Protect public health care system:
innovate based on evidence and capacity to engage patients,
and (4) Inform: provide education and transparency. With
Patients First as our framework, our leadership team and
technology partners jointly applied for, and secured, competitive
seed funding from the Michael G DeGroote Institute for Pain
Research and Care at McMaster University. With these funds,
a 2-day, international SMArTVIEW meeting was held for the
purposes of intervention codesign, systems integration planning,
and change management/scalability plan development. A
professional facilitation company, Guiding Star
Communications, led us through structured patient journey
mapping and analysis. Divided into working groups—each with
scientists; clinicians; CaVS patient representatives; engineers;
and information technology, policy, and knowledge translation
experts—we worked from stems of real CaVS cases to map the
typical senior patient’s recovery journey, based on experience.
We then engaged in facilitated analysis of what “must change.”
Once “must change” items were distilled and validated by
patient representatives, the technology partners showcased their
evidence-based innovations for change. Using consensus
techniques, we mapped partners’ solutions to “must change”
items in a codesign of the SMArTVIEW intervention. Three
subgroups worked intensively on systems integration.
Intervention Program, Technologies, and Effectiveness
Overview
SMArTVIEW is an eHealth-enabled service delivery
program—based on existing implementable technology and
validated interventions—which combines remote monitoring,
education, and self-management training (see Figure 1). The
following review of SMArTVIEW components as a whole
identifies key members of the health care team as well as key
phases and technology enablers.
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Figure 1. The Self-MAnagemenT—VIsion for patient EmpoWerment (SMArTVIEW) eHealth-enabled service delivery program. ECG: electrocardiogram.
Health Professionals Involved, Phases, and Technology
Enablers
Multiple clinicians are involved in seniors’ circles of care in
the hospital and the community. Successful implementation,
however, requires centralized coordination. Therefore, the
“SMArTVIEW Nurse” (SVN), a registered nurse with SVN
training, is central. SMArTVIEW is a two-stage intervention
program. Stage 1 supports seniors after CaVS in hospital on
surgical wards post-ICU, with a view to seamless transition,
while Stage 2 supports patients at home during the first 8 weeks
of recovery (see Figure 1). Across stages, our clinical technology
enablers include Philips’ IntelliVue Guardian [82] and Transition
to Ambulatory Care (eTrAC) Program [83], and QoC’s
Engagement Platform [84].
Stage 1
Stage 1 includes remote automated postoperative monitoring
(Protect) and pain management education (Protect, Inform).
Monitoring
On the ward, remote monitoring will be implemented by the
SVN via Philips’ IntelliVue Guardian early warning system,
which includes a centrally located monitor, a portable spot check
monitor, and four lightweight cableless devices worn by the
patient, with connectivity via short range radio and hotspot
transmitters. The four devices are as follows: (1) MX40,a
telemetry pack for 8-lead continuous electrocardiogram
monitoring; (2) Acquire SpO2, a wrist-worn device applied to
the index finger, which provides continuous SpO2 saturation
values under various artifact conditions, including motion and
low perfusion, as well as pulse rate; (3) Acquire Blood Pressure,
a noninvasive blood pressure cuff worn on the brachial aspect
of the arm; and (4) Acquire Respiration Pod, a small patch-like
device, attached to the left costal arch of the patient’s chest,
which derives respiration rate and patient posture via 3D
accelerometer [82]. Receiving data from each device, IntelliVue
Guardian software employs a deterioration notification algorithm
to facilitate early intervention. This algorithm automates hospital
early warning score (EWS) systems, normally performed
manually by clinicians. EWSs track vital sign deviations from
normal and trigger increasing attention to care, proportional to
the deviation. By virtue of automation, IntelliVue Guardian
efficiently verifies the accuracy of vital signs data by repeating
measurements at customized intervals [82]. If early signs of
deterioration are detected, IntelliVue Guardian will inform the
SVN via mobile device. Moreover, clinicians on the ward are
able to visualize EWS on the central monitor and spot check
monitor, which is kept at the patient's bedside. As identified
previously, remote automated monitoring is needed to identify
undetected hemodynamic compromise and allow for early
intervention to prevent adverse events following CaVS;
IntelliVue Guardian provides a comprehensive, evidence-based
solution [85] to meet this need.
Education
Education (Inform) is critical to prevent transition from acute
postop pain to CPSP. To empower seniors to know how to
communicate their postop pain experience and understand
options for pain management (Protect), we employ, on ward
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day 2, Watt-Watson et al’s Pain Relief After Surgery educational
intervention [46]. Adapted as an animated video module, Pain
Relief After Surgery is a 20-minute education tool, validated
for CaVS patients—comprehension level: Grade 6—and
designed to address common misbeliefs preventing patients
from asking for improved pain relief. Content also emphasizes
the individuality of pain responses and the importance of good
pain relief for optimal recovery at home. RCT evidence supports
the effectiveness of Pain Relief After Surgery for reducing
pain-related interference during recovery as well as misbeliefs
about analgesics [46]. In conjunction with Philips' eTrAC
program, this video module will be issued to the patient on ward
day 2.
Stage 2
Stage 2 includes SVN hospital-to-home remote monitoring and
support and self-management training.
Hospital-to-Home Remote Monitoring and Support
The eTrAC program is a tablet-based solution that combines
clinical software for effective care management with
Bluetooth-enabled, patient-monitoring devices measuring SpO2,
blood pressure, temperature, blood glucose, and weight [83].
Philips eTrAC allows clinicians to monitor discharged (ie,
at-home) patients’ vital signs status from the hospital (Protect),
and then prioritize them for required interventions (eg, signs of
sepsis evident) based upon a combination of
customized/standardized intervention rules [83]. eTrAC also
features customizable, interactive patient symptom and
self-report surveys to inform postoperative support and
management. SMArTVIEW-specific surveys include postop
daily symptoms, wound monitoring, sleep, nutrition, medication,
quality of life, and patient satisfaction. Interactive modules
assisting patient orientation to the system are also included. The
clinician interface for the eTrAC program is eCare Coordinator
(eCC), a cloud-based software tool designed to maximize
efficiency through risk prioritization— patients are assigned
overall scores calculated from weighted scores of self-report
surveys, measurements, issues, risk of readmission, and
discharge date if within the last 30 days. The overall score
generated allows clinicians to manage large patient populations
by triaging their interventions based on potential patient need
(ie, those with the highest scores are seen first). Through eCC,
clinicians can remotely manage patients, view and interpret
results (eg, vital signs and symptom and reflexive surveys),
follow up and intervene as needed, conduct video visits with
patients, and document all patient interventions and
observations.
The SVN will employ the eTrAC program to facilitate daily
virtual check-ins and counseling, daily vital signs monitoring
and triage, and review of interactive symptom and reflexive
surveys (Access, Inform, Protect, Connect) [83].
Self-Management Training
As with Stage 1, we are committed in Stage 2, combining
improved monitoring with education and support that empowers
seniors to proactively prevent transition to CPSP and prevent
poor functional recovery. As a team we are experienced in the
development/testing of self-management models for people
with coronary artery disease [86-88], other forms of chronic
illness [89,90], and CPSP [91]. In conjunction with postoperative
monitoring and support, participants will engage in
SMArTVIEW Restore. Restore is a virtual self-management
program, to be delivered in 2-hour sessions weekly, over a
7-week period, from week 0 (week of discharge) to week 6
postoperation (at home).
Figure 2 presents an overview of the Restore curriculum, based
on seniors’ CaVS recovery needs identified during patient
journey mapping, as well as lessons learned from our previous
self-management experience [86-91]. Both content and process
elements of Restore are grounded in the fear-avoidance beliefs
model [92], which shows how catastrophic pain perceptions
can lead to fear, hypervigilance, avoidance, disability, and
depression. The curriculum is designed to provide patients with
requisite cognitive, emotional, and behavioral skills to manage
their postop pain experience in a productive and positive way,
leading to optimal functioning. Restore will be run on a
time-release basis; interactive features will include weekly
recovery goal setting, interactive reflexive activities, wellness
journaling, a peer support forum, and a gratitude “wall.”
Both the online interactive elements as well as
self-efficacy-enhancing features of Restore will be adapted
specifically from the Coventry University Help to Overcome
Problems Effectively (HOPE) and Internet-based (iHOPE)
programs. As one of the first self-management interventions
combining positive psychology and cognitive behavioral therapy
theory, iHOPE includes evidence-based and positive
psychological activities such as goal setting, action planning,
identifying personal strengths, scheduling pleasant activities,
mindfulness, relaxation training, and reviewing successes [93].
Feasibility trials have shown that HOPE has the potential to
improve important quality-of-life outcomes for people living
with and affected by a range of long-term conditions [94,95].
Recently, Coventry University and Macmillan Cancer
Support—the United Kingdom’s leading charity and source of
cancer support—tested a Web-based version of HOPE (iHOPE)
for cancer survivors, comprised of six interactive Web-based
sessions, which combine cancer self-management information
and education with self-monitoring tools, worksheets, audio-
and video-based materials, interactive goal setting and gratitude
“walls,” and social networking via email and discussion forums.
Feasibility trial results showed that participants’ depression,
anxiety, fatigue, fear of cancer returning, positive mental
well-being, hope, and gratitude all significantly improved [95].
Participants’ course experience and usability ratings were high,
with all of the participants willing to recommend iHOPE to
other users [95].
To facilitate our adaptation of iHOPE interactive elements, QoC
Health’s Engagement Platform will be leveraged to customize
and integrate the validated modules (ie, feature sets) from their
existing platforms and to develop customized modules to
transform Restore from concept to a codesigned interactive
digital solution. QoC will apply the principles of user interface
and user experience design to create a user-friendly and intuitive
solution with reduced interface friction. An iterative,
user-centered design framework featuring participatory design
will be used to develop the Web-based solution, which will be
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optimized for tablet. QoC will facilitate codesign development
sessions with our patient representatives to ensure Restore is
aligned with their recovery needs and that it considers their
technical capabilities (eg, digital literacy and technology-savvy
level) and design preferences. The cognitive load on users will
be minimized by abating unnecessary decisions/steps and
inconsistencies in the interface. To offer the end user an
enhanced e-learning experience throughout Restore, the design
will feature “digital resting spaces.” This will be achieved by
applying the concepts of e-learning (eg, pacing and quantity
and diversity of content) and using the principles of white space
to balance content and segregate sections.
In summary, our technology partners are cutting-edge eHealth
innovators for change with evidence-based solutions. For
example, Philips’ IntelliVue Guardian has been shown to
significantly increase timely clinical response in hospital, based
on abnormal vital signs detection, as well as survival after rapid
response treatment [85]. Emerging evidence also suggests that
solutions developed through QoC’s Engagement Platform are
feasible, acceptable, and beneficial to postop patients and
surgical teams [96,97].
Figure 2. The Self-MAnagemenT—VIsion for patient EmpoWerment (SMArTVIEW) Restore curriculum. CaVS: cardiac and vascular surgery.
Systems Integration
SMArTVIEW deploys a highly integrated “system of systems.”
Multiple decentralized and heterogeneous subsystems, with
operational and managerial independence, are required to
provide our end-to-end SMArTVIEW solution. Our end goal
for clinical data management is to ensure that the right
information is provided to the right person, at the right time.
We have consulted extensively with our information technology
and clinical informatics experts to leverage existing assets
through systems architecture, as opposed to duplicating
functionality or existing data. Moreover, our technology
partners’ solutions meet Health Level 7 [98] industry standards
for seamless connection and bidirectional data exchange with
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our hospital information and electronic medical record systems.
We will also use application programming interfaces for the
extraction of data. We are confident we can achieve integrated
exchange of information, from hospital to home.
Privacy and Data Aggregation
Our additional partners, XAHIVE and mPath, serve as our chief
stewards of privacy and data aggregation, respectively. With
privacy paramount, we espouse a “privacy by design” approach
[99]. Privacy will be role based, highly configurable, and will
include the entire circle of care, including formal and informal
caregivers and supports by patient consent. To achieve these
objectives, we will employ XAHIVE’s secure communication
service platform, extensible using a custom off-the-shelf model.
The XAHIVE communication protocol does not require servers
in order to operate, nor does it require specific hardware devices;
these two factors give our team an advantage in the arena of
scalability of our deployments. XAHIVE will interface with
hospital information systems at both sites—Canada and the
United Kingdom—in order to realize (1) consistent security
across all communication touch points in the SMArTVIEW
system, and (2) a clear chain of custody on the privacy of data
per legislative requirements. SMArTVIEW involves multiple
“moving parts” that will generate data about recovering seniors’
status and behavior via peripheral devices. Additionally, the
solutions we use will generate and aggregate clinical
measurements in discrete locations. Third-party data sets (eg,
health services utilization data) will also be accessed, allowing
for correlations to be made beyond the scope of our integrated
systems. There are multiple considerations in the way data is
aggregated (eg, efficiency of architecture, reduction of
redundancy, and optimization of data accessibility). As leading
experts, mPath will govern our data aggregation practices.
Scalability
With scalability central to our vision, all partner solutions are
at technology readiness Level 9, with next to zero time to
solution required. Our scalability report will include
documentation of (1) unforeseen issues as they arise and
problem solving strategies, (2) patient and SVN experience,
and (3) results of our comprehensive econometrics evaluation
plan, distilled into a projected model of total cost of 1-year
SMArTVIEW patient throughput, based on site surgical
volumes.
Evaluation Plan Objectives
The objectives of the evaluation plan are to refine SMArTVIEW
(Phase 1) and conduct an RCT to examine its effectiveness.
Settings
Both evaluation plan phases will take place at Hamilton Health
Sciences, Hamilton, Canada, and Liverpool Heart and Chest
Hospital, the United Kingdom; the coordinating center is the
Population Health Research Institute, Hamilton, Canada.
Methods
Phase 1: Usability Testing
Participants
Included participants will be (1) aged ≥65 years, (2) undergoing
major CaVS with predicted admission >48 hours, and (3) able
to read, speak, and understand English such that reflexive
intervention surveys generated by eTrAC can be completed (ie,
Grade 6 reading level). Those excluded will have planned postop
admission or readmission to a nursing home or long-term care
facility.
Design and Procedures
Overview
Rogers’ methods for usability testing [100] will guide
SMArTVIEW refinement in the first 9 months. Patients and
clinicians will engage in two cycles of focus groups and usability
testing at each site, as described in the following sections.
Focus Groups
Two focus groups, one at each site, will each be conducted with
5 CaVS patients and 5 SVNs via an adapted semistructured
interview guide [101]. With well-established technology partner
solutions (ie, applications and devices), our focus is refining
overall system intervention flow and staging. After viewing still
images of each SMArTVIEW stage, feedback will be elicited
about (1) what is seen in each still, (2) expectations for engaging
with the SVN and eTrAC solutions at each stage, (3) what each
stage should accomplish, and (4) if conceptualization of
SMArTVIEW aligns with participants’ mental models of
required tasks.
Usability Testing
High-fidelity user testing of SMArTVIEW, focused on
intraoperability and flow of information, will involve a human
factors analyst, a research assistant (RA) with design
ethnography training, and the leadership team. Focus group
findings will be embedded into test (ie, simulated) clinical
scenarios, representing CaVS recovery issues. Using think-aloud
[102,103] protocols and task completion checklists, this usability
testing cycle—conducted twice, once at each site—will have
SVNs and patients rehearse all scenarios wherein information
coming from either player can be communicated, via automated
monitoring or self-report. Scheduled for 2 hours in the hospital
and 2 hours in the patient’s home soon after, but not on the same
day, rehearsals will be observed by the human factors analyst
and the RA. Through analysis of recorded usability testing data
to identify patterns of use, areas of satisfaction or frustration,
and system efficiencies and problems, the human factors analyst
and the RA will determine actions for system refinement
[104,105]. The entire cycle will be repeated, this time observing
real-time-based interaction.
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Phase 2: Randomized Controlled Trial
Methods
Trial Design
Research questions to be addressed in a two-group, parallel-arm
RCT (see Figure 3) include effectiveness of the intervention to
(1) improve postop pain at 30 days (primary outcome) and (2)
composite of major postop complications related to
hemodynamic compromise, HQRL, depressive symptoms, health
service utilization costs, and patient-level cost of recovery
(secondary outcomes).
Figure 3. Randomized controlled trial flow diagram. IWRS: Interactive Web Randomization System.
Participants
Participants will be included according to the inclusion/exclusion
criteria outlined in Phase 1, with two additional exclusion
criteria: (1) participation in Phase 1 and (2) positive Confusion
Assessment Method (CAM) screening upon transfer to the
surgical ward.
The Self-Management—Vision for Patient Empowerment
Intervention
The components of the SMArTVIEW intervention will be as
described under the Intervention Program, Technologies, and
Effectiveness section. The intervention delivery protocol, by
stage, is presented in Table 2. This protocol features SVN
support from the surgical ward 24 hours/day, 7 days/week.
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Table 2. SMArTVIEWa intervention delivery protocol by stage.
DetailsStages
Stage 1: In hospital
IntelliVue Guardian setup
(ward day 1)
Upon transfer to the ward, the IntelliVue Guardian early warning system is established by
the SVNb on duty, who connects patient to peripheral, cableless devices; establishes base-
line/normal vital signs with spot check monitor; activates IntelliVue Guardian; and performs
system checks every shift.
The SVN will receive alerts via mobile device; alerts will be set according to surgeon-
sanctioned vital signs parameters programmed into IntelliVue Guardian, which allow for
tailoring of profiles for day or night, as well as pre-existing comorbid conditions (eg, atrial
fibrillation).
Upon alerts, SVN assessment, intervention, and escalation of care will be according to usual
hospital protocols.
Patient and family pain education and hospital-
to-home orientation
(ward day 2)
The SVN will facilitate a 2.5-hour hospital-to-home orientation session implemented at the
convenience of the patient, supports (eg, family, friends, and caregivers), and clinical
workflow.
This orientation will focus on the eTrACc tablet-based applications, the PRASd educational
video, and Restore.
Following the orientation, the SVN will invite and answer questions.
Receipt of SMArTVIEW hospital-to-home
package and skills rehearsal
(day prior to discharge)
On the day prior to discharge, patients will receive their hospital-to-home packages from
the SVN, including eTrAC tablet-based solutions, instructions for monitoring vital signs at
home, eTrAC 30-day application schedule for monitoring vital signs, SVN video visits, and
daily recovery symptom and reflexive surveys.
Upon receipt of this hospital-to-home package, the SVN will facilitate a 30-minute checklist-
oriented rehearsal of all eTrAC features; the SVN will also invite and answer questions.
Stage 2: In the community
Setup (week 1 postdischarge)
Philips’ in-home installation team will work with the SVN to establish the Bluetooth-enabled
vital signs monitoring system.
The SVN will then commence monitoring of all incoming data from eTrAC via eCCe.
Patient monitoring and virtual check-ins
(first 30 days postdischarge)
The SVN will perform daily 15-minute virtual check-ins—eTrAC video visits—with patients
at home from the hospital via eCC, per hospital-to-home package instructions.
Virtual check-ins will include review of priorities flagged in eCC, review of vital signs and
symptom and reflexive survey data, postop pain assessment, and discussion of any pa-
tient/SVN concerns.
Issues identified—via eCC risk stratification or SVN assessment—that require intervention,
but are out of the scope of SVN practice, will be escalated to the most responsible clinician.
SMArTVIEW-Restore
(0 to 7 weeks postdischarge)
During recovery, participants will engage the Restore time-release, self-guided, online cur-
riculum (described previously).
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DetailsStages
Restore is structured according to seven weekly asynchronous modules, consisting of two
to seven activities each.
Restore is designed to constitute 2-3 hours of online activity, weekly.
aSMArTVIEW: Self-MAnagemenT—VIsion for patient EmpoWerment.
bSVN: SMArTVIEW Nurse.
ceTrAC: Transition to Ambulatory Care.
dPRAS: pain relief after surgery.
eeCC: eCare Coordinator.
Outcome Measures
Primary Outcome
The primary outcome is worst postop pain intensity upon
movement in the previous 24 hours—at 30 days after
randomization—averaged across the previous 14 days. This
will be assessed using the Brief Pain Inventory-Short Form
(BPI-SF), which has well-established reliability and validity in
surgical groups, including CaVS [15,106,107]. Common to
studies with postop pain as a primary outcome [15,106,107],
patients will report worst pain-intensity rating both upon rest
and movement in the past 24 hours. The primary outcome of
worst pain upon movement is a more reliable indicator of
suboptimal pain management and pain-related interference with
recovery-related activities than worst pain upon rest
[15,106,107].
Secondary Outcomes
Postoperative Complications Related to Hemodynamic
Compromise
We will capture a composite of complications related to
hemodynamic compromise up to 30 days postrandomization,
including death, myocardial infarction, and nonfatal stroke. The
number of events for the overall composite, as well as number
of events per component within the composite, will be reported.
All-Cause Mortality and Other Postoperative Complications
All-cause mortality will be captured up to 1 year
postrandomization. We will also monitor for new-onset atrial
fibrillation and SSI up to 30 days postrandomization.
Functional Status
The Short-Form 12 version 2 (SF-12v2) is an established,
reliable, and valid tool [108,109] to measure functional status
[108,109]. The SF-12v2 provides both physical component
summary and mental component summary scores [9,11,46,109].
Depressive Symptoms
The five-question version of the Geriatric Depression Scale
(GDS-5) will be used to measure depressive symptoms. This
tool is a well-validated instrument in the assessment of
depression in hospitalized older adults, with high levels of
sensitivity and specificity [110,111].
Chronic Postsurgical Pain
Development of CPSP is defined [112] as (1) pain that
developed after the surgical procedure, (2) being different from
pain experienced before surgery, and (3) being present for at
least 3 months. Patient responses in the affirmative to each of
these questions indicate patients have developed CPSP. For
patients who have developed CPSP, pain intensity and related
interference with usual daily activities will be measured via the
BPI-SF [106,107].
Heath Service Utilization-Related Cost
Data on hospital readmission and health care utilization and
costs of health service utilization data from the Canadian arm
of the trial will be linked with the health administrative Institute
for Clinical Evaluative Sciences data repository. Administrative
databases used to describe the health service utilization include
(1) Registered Persons Database—demographics and vital
statistics of all legal residents of Ontario, (2) Discharge Abstract
Database—records of inpatient hospitalizations—from the
Canadian Institute for Health Information (CIHI), (4) Ontario
Health Insurance Plan Database—physician billing claims, and
(5) the National Ambulatory Care Reporting
System—information on emergency department visits—from
CIHI. In addition, to capture data on times spent on the portal
by health providers (eg, pharmacists and nurses), costs of health
providers’ time will be captured in the system reporting. Costs
of health providers’ time on the portal will be calculated by
multiplying the time with unit costs from standard costing
sources in Ontario.
Patient-Level Cost of Recovery
The Ambulatory and Home Care Record (AHCR) [11,113-117]
will be used to comprehensively measure patient-level cost of
illness from a societal perspective (Canada and the United
Kingdom). This approach gives equal consideration to health
system costs and costs borne by patients and unpaid caregivers
(eg, family members and friends). AHCR items can be
categorized as publicly financed (eg, public sector paid
resources) or privately financed care (eg, all out-of-pocket and
third-party insurance payments, and time costs incurred by
caregiver). Face validity and reliability of the AHCR is
well-established in multiple groups, including CaVS patients
[11,113-117].
Baseline Measures to Inform Subgroup Analyses
Aside from baseline clinical and demographic information,
gender-based pain expectations [118] will be assessed to inform
subgroup analyses as evidence suggests that gender-based pain
expectations may lead to differences in the experience of pain
and related response to interventions [118]. These expectations
will be captured using the Gender Role Expectations of Pain
(GREP) tool, which captures stereotypic attributions regarding
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pain endurance, pain sensitivity, and willingness to report pain.
The GREP tool has been used in multiple pain investigations
[118-123] with acceptable test-retest and internal consistency
reliability [118].
Baseline digital literacy will also be assessed using an adapted
version of the informational and instrumental support domains
of the Patient-Reported Outcomes Measurement Information
System (PROMIS) measures. This approach, previously
pilot-tested with cardiovascular patients [124], employs five
items to examine current level of engagement with mobile and
digital technologies.
Follow-Up
The SVN will collect outcome data for intervention and control
groups following random allocation through discharge. Once
in the community, patients in both groups will record their
BPI-SF pain scores daily for 8 weeks using the tablet-based
solutions. Data on 30-day event rates (ie, major postop
complications) and hospital readmissions for both groups will
be collected by a blinded RA via telephone interview at 30 days
postoperation. At 3, 6, 9, and 12 months, additional telephone
interviews conducted by the RA will assess (1) functional status,
(2) depressive symptoms, (3) CPSP, and (4) patient-level cost
of recovery (ie, AHCR).
Qualitative Data Collection
To understand patient experience with CaVS recovery and
involvement with the SMArTVIEW intervention, we will
conduct telephone interviews with 60 patients and 60 primary
support persons in the intervention and control groups and with
all SVNs (n=20) using a semistructured interview guide. The
interviews will focus on perceptions of usability and ethical,
social, and legal issues. Our sample size should ensure data
saturation [125].
Sample Size
Assuming a two-sided type I error (alpha) of .05 and a standard
deviation of 20 points in BPI-SF numeric rating scale scores
(range 0-100), a total of 128 participants (ie, 64 individuals in
each group) are required to provide 80% power to detect a
minimally important difference of 10 points. This difference
represents a moderate effect size (Cohen’s d=0.50) [126].
Assuming a 10% loss to follow-up, 144 total patients (or 72 per
group) is required. We will use this sample size for each site,
to allow for site-specific analyses with equal and sufficient
power. If there is sufficient homogeneity between the Canadian
and UK samples, the combined sample (eg, 256 patients with
complete data) would provide 80% power to detect a difference
in pain intensity scores of 8.6 points (Cohen’s d=0.43), assuming
a generous design effect [127] of 1.5 due to the clustering of
participants within the site.
Recruitment
Strategies previously developed will be applied [3,6]; RAs will
screen preoperative surgical patient lists daily. Anesthesia,
CaVS, and medicine services will contact the RAs for all CaVS
admissions through emergency and new consultations. Eligible
patients will be approached and invited. Patients providing
informed consent will be registered via the Interactive Web
Randomization System (IWRS), a 24-hour, central,
computerized, secure (ie, password-protected), Web-based
registration/randomization service at the Population Health
Research Institute, and baseline data will be collected. Patients
undergoing urgent surgeries will be approached postoperation.
Randomization and Allocation
Blocked randomization (ie, randomly assigned block sizes) will
be used to achieve balanced allocation of intervention and
control groups. The randomization allocation list will be
prepared by Population Health Research Institute statisticians
and integrated into the IWRS system. Upon transfer to the
surgical ward (ie, post-ICU), the SVN will assess consented
patients using the CAM. If CAM scores do not indicate cognitive
impairment or delirium and the patient remains eligible, they
will be randomly allocated by the IWRS.
Feasibility
Our technology partners have contributed equipment and
personnel time, in-kind, such that we are able to intervene and
follow up on 15 patients at one time per site throughout the
study until 30 days follow-up, at which time equipment will be
returned to each hospital site for cleaning and reset. Therefore,
the RCT (Phase 2) will be executed in five serial, parallel waves
of approximately 30 patients per site. In 2014, there were 2311
and 1974 CaVS performed at Hamilton Health Sciences,
Canada, and the Liverpool Heart and Chest Hospital, the United
Kingdom, respectively. Planned recruitment will occur at a rate
feasible for SVN time and access to the surgical populations at
both sites. Patients will be enrolled during a 3-week period,
with the last week of each recruitment month available for
additional patient registrations as needed to accommodate those
not meeting postop eligibility. Each site will target recruitment
of 14 cardiac and 16 vascular patients during 3 weeks of
recruitment—10 patients per week, per site. Allowing for a 25%
refusal rate, lost opportunities, and competing studies, this still
provides access to 20 patients at Hamilton Health Sciences and
17 patients at the Liverpool Heart and Chest Hospital. Since
participant recruitment is only limited by prototype availability,
our proposed recruitment target and timeline is feasible and
recruitment of 300 participants will be completed in 10 months’
time.
Data Analyses
Primary Analyses
Table 3 summarizes all data analyses. Using the intent-to-treat
principle [128], all patients will be included in the final analysis
and according to the group to which they were randomly
allocated. Descriptive statistics will be used to describe sample
characteristics using measures of central tendency and dispersion
for continuous factors, and frequencies and proportions for
categorical factors. A two-sided significance level of .05 will
be used for all inferential analyses. Statistical methods used will
depend on the type and distribution of data for the outcome
variable under study. If outcome data meet requirements for
parametric statistics, a linear mixed model [129] will be used
to assess the effects of the intervention on the primary outcome.
An a priori contrast of the weekly average worst score for the
BPI-SF numeric rating scale upon movement (previous 24 hours)
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will be used to evaluate the primary endpoint of acute postop
pain at 30 days postrandomization.
Linear mixed models, using an autoregressive [130] covariance
structure—allowing for correlations between measurements to
decline as they are further apart in time—will be used to evaluate
within-patient variation in patient-reported outcomes over 12
months of follow-up. Linear mixed models are a flexible and
powerful approach to the analysis of data with a complex
variance structure, such as correlated data [129-131]. Unlike
traditional repeated-measures designs, these models do not
require complete data on each patient and have increased
statistical power [132]. Nonlinear mixed models will be used
in the following cases: (1) if continuous data violate assumptions
of normality [132] and (2) for categorical secondary outcomes
(eg, adverse event). Chi-square tests of association will be used
to assess the association between categorical secondary
outcomes identified in the administrative data and intervention.
Given that the data is derived from an RCT, complex modeling
for these outcomes will not be performed, as potential
confounders are considered to be adjusted for in the design.
Finally, we will examine patterns of missing data and determine
demographic and/or clinical characteristics that are related to
missing data at each time point, and the potential impact on the
primary findings.
Secondary Analysis
A secondary analysis will aim to establish the cumulative impact
of the components of the intervention (eg, remote monitoring
and self-management training) on outcomes and assess “digital
retention” and sustained digital device usage in visual and
time-sensitive analyses using an N-of-1 design (see Table 3).
N-of-1 designs use a patient as their own control and can assess
the impact of incremental changes with respect to the
intervention with frequent and repeated measurements of the
outcome variable of interest (ie, pain over time) and are
particularly applicable to digital health and mobile phone-based
clinical trials [133]. An N-of-1 design allows for association of
causality to interventions in real time and direct methods to
estimate individual treatment effects and variation per patient.
Using the funnel approach, an individual patient is observed
repeatedly to graphically demonstrate the variation in pain and
HRQL over time [134].
Subgroup Analyses
Two types of separate subgroup analyses are planned to
determine the impact of gender-based pain expectations and
patient sex on intervention effectiveness (see Table 3):
1. Patients will be stratified into high versus low GREP scores.
The primary analyses examining the effect of the intervention
on the worst score for the BPI-SF numeric rating scale upon
movement (previous 24 hours) will be conducted. An interaction
term for GREP score (low versus high) and the group allocation
will be incorporated into the analyses to determine if
gender-based pain expectations are associated with differences
in the effect of the intervention on the primary outcome. If a
significant interaction is identified, the primary analysis in these
two groups will be performed.
2. Similarly, interaction between the intervention and patient
sex will be examined.
Cost-Effectiveness Analyses
The cost-effectiveness of implementing the intervention will
be determined from two perspectives: (1) the Ministry of Health
and Long-Term Care (MoHLTC) (Canada) and (2) society
(Canada and the United Kingdom) (see Table 3). Separate
analyses will be conducted from each perspective. MoHLTC
costs will include costs associated with health service utilization
over the study period (eg, hospitalization, emergency room
visits, day surgery or procedure, laboratory services, outpatient
visits, prescription drugs, and home care services from the
Institute of Clinical Evaluative Sciences). Time that health
providers (eg, pharmacists) spent on the SMArTVIEW portal
will be calculated by multiplying the time with unit costs from
standard costing sources in Ontario. From the societal
perspective, costs will include those from the MoHLTC
perspective, including costs incurred to patients and family
members (eg, travel cost and productivity loss), which will be
captured through the AHCR.
The first economic analysis outcome is the incremental cost of
the intervention compared to usual care. We will analyze the
total cost as a dependent variable, using a regression model to
estimate the difference in expected health care cost between the
two groups. The intervention will be the primary independent
variable and the regression model will adjust for potential
confounding variables. In theory, an ordinary least squares
model produces unbiased estimates even if the data are skewed
[135,136]; however, additional estimation methods (eg,
generalized linear models) and different uncertainty methods
(eg, parametric and nonparametric bootstrapping) will be
explored to facilitate investigation of the impact of various cost
assumptions.
As a secondary cost objective, we will compare the cost and
quality-adjusted life years (QALYs) between the two groups
using the net benefit regression framework (see Table 3). QALY
is a preference-based utility measure of HRQL, as perceived
by the patient, that incorporates both length of life and quality
of life into a single measure [137,138]. We aim to determine
the incremental net benefit of interventions versus usual care.
To estimate QALYs gained, we will convert SF-12v2 data
collected to utility scores using a validated algorithm. We will
also estimate the incremental cost per QALY gained. A
cost-effectiveness acceptability curve (95% CI) will be used to
characterize the uncertainty of our findings [139].
Uptake of Technology
Data on uptake of the SMArTVIEW intervention will be used
to explain differences in the outcome measures, determine
patterns of use to predict outcomes, and identify users who may
require escalated care. Session frequency (ie, times the
technology is accessed) and session length (ie, length of time
users interact with the technology) [140] will be determined via
daily metrics of both device and application use. During Phase
1, mPath will identify all key actions of SMArTVIEW to
generate a template for relevant data collection at a granular,
individual user level.
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Table 3. Summary of outcomes, hypotheses, measures, and methods of analysis.
Method of analysisOutcome measureHypothesisOutcomeAnalyses
Primary
outcome
Linear mixed model or nonlinear
mixed models (if assumptions of
normality are violated)
Measured by Brief Pain Inventory-
Short Form (BPI-SFa)
Intervention > control8-week worst postop pain inten-
sity upon movement score in the
past 24 hours
Secondary
outcome
Linear mixed model or nonlinear
mixed models (if assumptions of
normality are violated)
Short-Form 12 version 2Intervention > controlFunctional status
Linear mixed model or nonlinear
mixed models (if assumptions of
normality are violated)
Five-question version of the Geri-
atric Depression Scale
Intervention > controlDepressive symptom scores
Nonlinear mixed modelsMyocardial infarction and strokeIntervention > controlPostop complications related to
hemodynamic compromise
Nonlinear mixed modelsSurgical site infection, presence of
CPSPb
Intervention > controlOther relevant postop complica-
tions
Linear mixed model or nonlinear
mixed models (if assumptions of
normality are violated)
Linked with health administrative
Institute for Clinical Evaluative
Sciences data repository
Intervention > controlHeath service utilization-related
cost
Linear mixed model or nonlinear
mixed models (if assumptions of
normality are violated)
Ambulatory and Home Care
Record
Intervention > controlPatient-level cost of recovery
Subgroup
outcomes
Interaction testWorst postop pain intensity upon
movement score in the past 24
hours measured by BPI-SF numer-
ic rating scale
Effect will differ by gender
(male versus female)
All outcomes
Interaction testWorst postop pain intensity upon
movement score in the past 24
hours measured by BPI-SF numer-
ic rating scale
Effect will differ by
GREPc scores (low versus
high)
All outcomes
aBPI-SF: Brief Pain Inventory-Short Form.
bCPSP: chronic postsurgical pain.
cGREP: Gender Role Expectations of Pain.
Qualitative Analyses
Qualitative Description
Data will be digitally recorded, transcribed verbatim, and
managed in NVivo 11 (QSR International). Concepts that relate
to the usability and value of the intervention will be coded [141]
and reviewed by investigators to resolve differences and
minimize biases [141]. Revisions to the interview guide and
codebook will reflect emerging themes.
Critical Qualitative Analysis
To reveal the ethical, legal, and social implications of the
intervention, we will apply methods used successfully in
previous research [142]. Following this, data will be
re-examined using four bioethical concepts—relational
autonomy, care, social justice, and privacy—to draw out the
normative implications of the intervention which are sensitive
to ethical issues common to at-home care for seniors [143]. A
retroductive process will be used that involves moving between
observations and concepts and allows the interplay between
individuals’ lives and larger social and contextual forces to be
understood [144,145]. The four concepts will not be used simply
as containers to categorize data uncritically to aid in the social
and ethical analysis of the data. Rigor will be maintained by
keeping a reflexive journal and audit trail [141] and ensuring
that the purpose of the research, theoretical assumptions, and
method of data analysis are congruent [146].
Controls for Bias
To limit sampling bias, a recruitment schedule randomly
generated to ensure representation from each surgical group
will be used. Contamination should not exist between groups
as we will control who interacts with the SVN and intervention
features. Those allocated to the intervention group will be asked
not to share their tablets or demonstrate application features to
any peers assigned to the control group. To evaluate
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cointervention, we will track participant receipt of any
monitoring or recovery support-related interventions, outside
of expected usual care up to 8 weeks postoperation. RAs
responsible for outcome data collection will be separated from
randomization procedures, will have no permitted access to
IWRS, will not be involved in intervention delivery, and will
be blinded to group allocation. An event adjudication committee
responsible for adjudication of all clinical outcome data will be
blinded to randomized allocation. The team has extensive
experience with assiduous follow-up procedures to minimize
losses to follow-up.
Knowledge Translation
Integrated knowledge translation strategies will continue to
involve stakeholder groups during the project. As part of
integrated and end-of-grant knowledge translation, stakeholders
will assist in interpreting findings, identifying key results, and
reviewing and revising the end-of-grant knowledge translation
plan at a final meeting for review of investigator results.
End-of-grant knowledge translation goals—generate interest,
discussion, and awareness; impart knowledge; and inform
research—will be addressed via tailored implementation
strategies.
Results
Study start-up is underway and usability testing is scheduled to
begin in the fall of 2016.
Discussion
THE SMArTVIEW, CoVeRed innovation community brings
together an international, dedicated group of well-known clinical
and eHealth researchers; health economists; clinicians;
administrators; patient representatives; engineers, information
technology, and clinical informatics experts; as well as leaders
in the arenas of health policy, big data and data aggregation,
bioethics, knowledge translation, and privacy. Collectively, we
possess the requisite skills, experience, and track record to
execute the proposed evaluation, disseminate what we learn,
and plan for diffusion of innovation.
We are actively engaged in systems integration and change
management at both study sites. As a result of planned, shared
stewardship of our vision, we have fostered a milieu of
co-ownership and investment in SMArTVIEW usability and
effectiveness testing. With respect to end-user engagement, we
understand well from experience that innovation is not a linear
process. We are committed to recursive coinnovation between
“solutioner” and end users. Hence, corefinement of
SMArTVIEW— via usability testing in context—was a key
objective identified during team debriefing, following our patient
journey mapping exercise. Akin to the use of “experimentation
suites” in the industry sector, our process, as outlined within
the Usability Testing section, will be to immerse with
participants in high-fidelity rehearsal of SMArTVIEW activities
in order to uncover ways we can refine our processes to optimize
the experience of recovery for seniors following CaVS. Our
team, including patient representatives, is organized into both
content and governance committees (see Table 4).
In collaboration with our industry partners, Canadian and UK
hospital sites, we are confident that we have the experience,
expertise, infrastructure, and support to realize THE
SMArTVIEW, CoVeRed. A copy of our Canadian Institutes of
Health Research (CIHR) reviews can be found in Multimedia
Appendix 2.
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Table 4. SMArTVIEWa team committees.
Committee nameCommittee type
Content
Clinical Transformation/Change Management
Clinical Monitoring
Patient Engagement and Experience
Economics
Knowledge Translation
Systems Integration
Self-Management
Clinician and SVNb Training
Ethics
Governance
Project Office Operations
International Operations
Steering
Outcomes Adjudication
External Safety
Efficacy and Monitoring
Substudy and Publications
aSMArTVIEW: Self-MAnagemenT—VIsion for patient EmpoWerment.
bSVN: SMarTVIEW Nurse.
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Abbreviations
AHCR: Ambulatory Home Care Record
BPI-SF:  Brief Pain Inventory-Short Form
CAM:  Confusion Assessment Method
CARD:  Cardiac
CaVS:  cardiac and vascular surgery
CIHI:  Canadian Institute for Health Information
CIHR:  Canadian Institutes of Health Research
CPSP:  chronic postsurgical pain
eCC:  eCare Coordinator
ECG:  electrocardiogram
eTrAC: Transition to Ambulatory Care
EWS:  early warning score
GDS-5:  five-question version of the Geriatric Depression Scale
GREP:  Gender Role Expectations of Pain
HOPE:  Help to Overcome Problems Effectively
HR:  hazard ratio
HRQL:  health-related quality of life
ICU:  intensive care unit
iHOPE:  Internet-based Help to Overcome Problems Effectively
IWRS:  Interactive Web Randomization System
MoHLTC:  Ministry of Health and Long-Term Care
N/A:  not applicable
PCI:  percutaneous coronary intervention
POISE:  PeriOperative ISchemic Evaluation
postop:  postoperative
PRAS:  pain relief after surgery
PROMIS:  Patient-Reported Outcomes Measurement Information System
QALY:  quality-adjusted life year
RA:  research assistant
RCT:  randomized controlled trial
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SVN:  SMArTVIEW Nurse
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